At the same time, the lung metastasis in groups treated with IL-6 was slight increased, which was consistent with the tumor promotion effect of IL-6 in SPC-A-1 subcutaneous xenograft cancer model (Fig. 6c). The gene discussed is IL6; the disease is cancer.